文献速递妇科

卵巢交界性肿瘤的新超声标志:乳头状突起和实性成分的微囊型模式

New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components.
PubMed 文献 · Ultrasound Obstet Gynecol · 2019-08-08

本回顾性研究纳入62例患者(67个卵巢)经手术病理确诊的卵巢交界性肿瘤(BOT),评估术前经阴道超声(TVS)中乳头状突起、实性成分和/或分隔的微囊型模式(1-3mm薄壁液性囊腔簇)作为BOT超声标志的效用。TVS显示67个BOT中60个(89.6%)存在微囊型模式,组织学检查60个(89.6%)样本有类似1-3mm液性囊腔;20例良性囊腺瘤和20例上皮性卵巢癌均无此微囊特征(TVS和组织学)。PubMed检索23篇英文文献含163幅BOT超声图像,均未描述该微囊组织模式。

要点

  • TVS显示67个BOT中60个(89.6%)存在微囊型模式,包括47个浆液性BOT中46个(97.9%)、15个黏液性BOT中11个(73.3%)、5个浆液黏液性BOT中3个(60.0%)。
  • 组织学检查60个(89.6%)样本有特征性1-3mm液性囊腔,与TVS所见相似;7例TVS与组织学微囊型模式观察不一致。
  • 20例良性囊腺瘤和20例上皮性卵巢癌在TVS和组织学上均未显示微囊特征。

核心结论

  • 作者报告BOT乳头状突起、实性成分和/或分隔的微囊型模式是一种新的超声标志,见于多数浆液性和黏液性BOT病例。
  • 基于良恶性病变超声图像与组织病理学比较,微囊外观似乎为BOT所特有,此前文献未见类似描述。
  • 作者认为利用该新标志应有助于正确识别BOT、将其与卵巢癌和良性卵巢病变区分,并应确保适当的临床和手术管理。

研究设计与样本

  • 回顾性研究,纳入经手术切除后组织学确诊BOT且术前接受经阴道超声(TVS)检查的女性。
  • 最终分析62例患者(67个卵巢),手术时平均年龄39.8岁,TVS所示BOT平均大小60.7mm。
  • 从同一超声和手术数据库随机选取20例上皮性卵巢癌和20例良性囊腺瘤,由同一病理学家复核。
  • 检索PubMed 2010年至2018年发表的英文文献,以确认微囊组织模式与BOT的关联是否曾被描述。

主要发现

  • 67个BOT中47个(70.1%)为浆液性、15个(22.4%)为黏液性、5个(7.5%)为浆液黏液性。
  • TVS显示67个BOT中60个(89.6%)乳头状突起、实性成分和/或分隔存在微囊型模式。
  • TVS微囊型模式见于47个浆液性BOT中46个(97.9%)、15个黏液性BOT中11个(73.3%)、5个浆液黏液性BOT中3个(60.0%)。
  • 组织学检查67个样本中60个(89.6%)有特征性1-3mm液性囊腔,与TVS所见相似;7例TVS与组织学微囊型模式观察不一致。
  • 20例囊腺瘤多为单房和/或多房且大部分无血管,20例囊腺瘤和20例上皮性卵巢癌在TVS和组织学上均未显示微囊特征。

临床怎么用

  • 作者认为利用该新标志应有助于正确识别BOT,将其与卵巢癌和良性卵巢病变区分,并应确保适当的临床和手术管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe and evaluate the utility of a new sonographic microcystic pattern, which is typical of borderline ovarian tumor (BOT) papillary projections, solid component(s) and/or septa, as a new ultrasound marker that is capable of distinguishing BOT from other adnexal masses, and to present/obtain histologic confirmation. METHODS: In this retrospective study, we identified women with a histologic diagnosis of BOT following surgical resection who had undergone preoperative transvaginal ultrasound (TVS) examination. All images were reviewed for presence or absence of thin-walled, fluid-filled cluster(s) of 1-3-mm cystic formations, associated with solid component(s), papillary projections and/or septa. From the same cases, histopathologic slides of each BOT were examined for presence of any of these microcystic features which had been identified on TVS. To confirm that the microcystic TVS pattern is unique to BOTs, we also selected randomly from our ultrasound and surgical database 20 cases of epithelial ovarian cancer and 20 cases of benign cystadenoma, for review by the same pathologists. To confirm the novelty of our findings, we searched PubMed for literature published in the English language between 2010 and 2018 to determine whether the association between microcystic tissue pattern and BOT has been described previously. RESULTS: Included in the final analysis were 62 patients (67 ovaries) with preoperative TVS and surgically confirmed BOT on pathologic examination. The mean patient age at surgery was 39.8 years. The mean BOT size at TVS was 60.7 mm. Of the 67 BOTs, 47 (70.1%) were serous, 15 (22.4%) were mucinous and five (7.5%) were seromucinous. We observed on TVS a microcystic pattern in the papillary projections, solid component(s) and/or septa in 60 (89.6%) of the 67 BOTs, including 46 (97.9%) of the 47 serous BOTs, 11 (73.3%) of the 15 mucinous BOTs and three (60.0%) of the five seromucinous BOTs. On microscopic evaluation, 60 (89.6%) of the 67 samples had characteristic 1-3-mm fluid-filled cysts similar to those seen on TVS. In seven cases there was a discrepancy between sonographic and histologic observation of a microcystic pattern. The 20 cystadenomas were mostly unilocular and/or multilocular and largely avascular. None of them or the 20 epithelial ovarian malignancies displayed microcystic characteristics, either on TVS or at histology. On review of 23 published articles in the English medical literature, containing 163 sonographic images of BOT, we found that, while all images contained it, there was no description of the microcystic tissue pattern. CONCLUSION: We report herein a novel sonographic marker of BOT, a 'microcystic pattern' of BOT papillary projections, solid component(s) and/or septa. This was seen in the majority of both serous and mucinous BOT cases. Importantly, based on comparison of sonographic images and histopathology of benign entities and malignancies, the microcystic appearance seems to be unique to BOTs. No similar description has been published previously. Utilization of this new marker should help to identify BOT correctly, discriminating it from ovarian cancer and benign ovarian pathology, and should ensure appropriate clinical and surgical management. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Timor-Tritsch IE, Foley CE, Brandon C, et al. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components. Ultrasound Obstet Gynecol. 2019. PMID: 30950132. doi:10.1002/uog.20283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。